Study: Telehealth Utilization Remains High Within Mental Healthcare
Mental healthcare has the highest telehealth usage rate and the highest no-show odds, researchers report
Read More
Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics is cutting discovery and preclinical work to focus on its clinical-stage cancer drugs. The most advanced program is camonsertib, whose rights Repare recently regained from Roche after the pharma giant terminated an alliance started in 2022. The post Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline appeared first on MedCity News.
Patients Everywhere Deserve Safer Care – Here’s How We Get There
Healthcare organizations tend to view issues in pockets – how they are impacting their specific organization and region – but patient safety is a collective mission. No matter what hospital or health system they are in, or which care model they belong to, patients everywhere deserve safer care. The post Patients Everywhere Deserve Safer Care…
In the Pharmaceutical Industry, Ethics are Still More Valuable Than AI
This responsibility goes beyond mere box-ticking; it requires a deep, introspective examination of our own biases and blind spots and a genuine commitment to putting the well-being of the communities we serve first. The post In the Pharmaceutical Industry, Ethics are Still More Valuable Than AI appeared first on MedCity News.
The Promise of Value-Based Care and MedTech Innovation
Monica Vajani, Executive Director for mHUB’s MedTech Accelerator, discusses how mHUB is helping innovators transition healthcare towards value-based care. The post The Promise of Value-Based Care and MedTech Innovation appeared first on MedCity News.
Fake News from MedPac on Medicare Advantage Needs to Be Corrected, Part 2
By GEORGE HALVORSON Special Needs Plans Change Lives for The Lowest Income and Highest Need Patients The people who benefit the most from Medicare Advantage are clearly the very low-income and high health-need people who are eligible for both Medicare and Medicaid as programs and who enroll as members in the Medicare Advantage Special Needs…
Value Assessment Approaches for Duchenne Muscular Dystrophy Therapies
Check out my new paper titled “Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies“. The abstract is below. Purpose: Traditional value assessment frameworks are challenged in comprehensively assessing the societal value new therapies bring to individuals with rare, progressive, genetic, fatal, neuromuscular diseases such as Duchenne muscular dystrophy (DMD). The…
Can appointment-based models (ABM) reduce total cost of care?
Managing multiple medications is a challenge for many individuals, particularly the elderly. One study by Almodóvar et al. (2019) found that among Medicare beneficiaries eligible for medication therapy management (MTM), 51% had used 11 or more medications. One approach to improving medication management is to use an appointment-based model (ABM) and other forms of medication…
The Surprising Rivalries-Turned-Friendships That Are Shaping Diabetes Technology
Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space. The post The Surprising Rivalries-Turned-Friendships That Are…
Why Pfizer Is Dipping Into DTC Telehealth With PfizerForAll
To address the complicated healthcare landscape in the U.S., Pfizer launched a new direct-to-consumer virtual service called PfizerForAll. It follows Eli Lilly, which launched a similar product in January. The post Why Pfizer Is Dipping Into DTC Telehealth With PfizerForAll appeared first on MedCity News.